|
Real-time
OTC Markets
15:30:58 02/06/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0711 USD | -15.16% |
|
+5.33% | +16.08% |
| 08-12 | Radnostix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-24 | Radnostix, Inc. acquired Certain Assets of Lucerno Dynamics, LLC for 1.65 million. | CI |
| Market Cap | 35.35M 30.29M 28.34M 25.91M 48.89M 3.38B 49.41M 335M 130M 1.7B 133M 130M 5.62B | P/E 2024 |
2,150x | P/E 2025 | -35.5x |
|---|---|---|---|---|---|
| Enterprise Value | 42.55M 36.47M 34.12M 31.19M 58.86M 4.07B 59.49M 404M 157M 2.05B 160M 156M 6.77B | EV / Sales 2024 |
1.76x | EV / Sales 2025 | 3.03x |
| Free-Float |
26.54% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -15.16% | ||
| 1 week | +5.33% | ||
| Current month | +1.72% | ||
| 1 month | +14.22% | ||
| 3 months | -2.74% | ||
| 6 months | -11.12% | ||
| Current year | +16.08% |
| 1 week | 0.05 |  | 0.08 |
| 1 month | 0.05 | | 0.08 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.05 | | 0.11 |
| 3 years | 0.02 | | 0.11 |
| 5 years | 0.02 | | 0.12 |
| 10 years | 0 | | 0.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shahe Bagerdjian
CEO | Chief Executive Officer | 42 | 31/08/2023 |
W. Cox
DFI | Director of Finance/CFO | 42 | 29/09/2019 |
John Miller
LAW | General Counsel | 61 | 31/12/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Steve Laflin
BRD | Director/Board Member | 69 | 31/05/2001 |
| Chairman | 58 | 30/06/2017 | |
Robert Atcher
BRD | Director/Board Member | 74 | 01/08/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/10/25 | Free | Director | 250,000 | 0.0478% | ||
| 10/10/25 | Free | Chairman | 500,000 | 0.0955% | ||
| 10/10/25 | Free | Director | 500,000 | 0.0955% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -15.16% | +5.33% | -20.02% | +29.27% | 35.35M | |
| -0.08% | -1.28% | -11.87% | -30.23% | 2.54B | |
| -3.51% | +0.11% | +0.78% | -84.31% | 1.98B | |
| +2.48% | +0.51% | -14.57% | -1.10% | 353M | |
| +1.82% | -5.49% | -48.27% | - | 50.77M | |
| Average | -2.85% | +0.50% | -18.79% | -21.59% | 992.54M | |
| Weighted average by Cap. | -1.27% | +0.34% | -7.44% | -49.56% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.9M 11.91M 11.14M 10.19M 19.23M 1.33B 19.43M 132M 51.27M 668M 52.19M 51.06M 2.21B | 13.07M 11.2M 10.48M 9.58M 18.08M 1.25B 18.27M 124M 48.22M 628M 49.08M 48.01M 2.08B |
| Net income | 8.57K 7.35K 6.87K 6.28K 11.86K 821K 11.99K 81.34K 31.63K 412K 32.19K 31.5K 1.36M | -908K -778K -728K -666K -1.26M -86.94M -1.27M -8.61M -3.35M -43.66M -3.41M -3.34M -144M |
| Net Debt | 6.42M 5.5M 5.14M 4.7M 8.87M 614M 8.97M 60.87M 23.67M 309M 24.09M 23.57M 1.02B | 7.21M 6.18M 5.78M 5.28M 9.97M 690M 10.07M 68.36M 26.58M 346M 27.06M 26.47M 1.15B |
Employees
45
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | US$0.0668 | +4.37% | 300 |
| 20/08/26 | US$0.0640 | +14.29% | 44,897 |
| 19/08/26 | US$0.0560 | -11.53% | 47,307 |
- Stock Market
- Stocks
- INIS Stock
Select your edition
All financial news and data tailored to specific country editions
